Publication date context 2026 02 19. This regulatory style briefing summarizes a not yet recruiting clinical trial listed on ClinicalTrials.gov that targets pneumonia in children aged 6 to 36 months. The intervention arms listed are Placebo and two combination products named Navax and Navax PregMom. The sponsor is Anabio R&D. The entry notes the not yet recruiting status, signaling that enrollment has not started. The posting illustrates how pediatric device and combination product pathways may be navigated in the early stages of development and what regulatory watchers should monitor as the program progresses.
What is the study about?
The listing centers on pneumonia in children and includes a combination product named Navax along with a Navax PregMom variant. A placebo arm is listed for comparison. The sponsor is Anabio R&D. The entry does not provide efficacy data and uses the term not yet recruiting to indicate that participant enrollment has not begun. The listing serves as an early signal of a regulatory pathway exploring device and therapeutic components in a pediatric pneumonia setting.
What interventions are tested?
- Other: Placebo
- Combination Product Navax
- Combination Product Navax PregMom
What are the regulatory implications for pediatric device trials?
The reference to a combination product implies an interplay between device like elements and therapeutic components under the regulatory framework for combination products. The entry presents a scenario where safety, performance and labeling considerations will be central to any future submission. The page itself provides only administrative details such as the study arm description and sponsor; it does not include efficacy outcomes. Stakeholders should anticipate formal filings or communications that clarify intended use, risk management measures and compliance with relevant pediatric device and medical product requirements.
What is the current status and who sponsors?
The trial status is Not yet recruiting, indicating that no participants have been enrolled yet. The sponsor listed is Anabio R&D. Given the designation combination product this trial may involve device components in addition to a therapeutic approach. Regulators, investigators and institutional review boards will monitor updates and ensure alignment with pediatric safety standards and appropriate consent processes as the program advances.
What does this mean for patients and clinicians?
At this stage there is no evidence regarding safety or efficacy. The information serves as a notice of potential future options rather than a recommendation for care. Clinicians should await robust clinical data and adhere to local guidelines for pneumonia management in children aged 6 to 36 months. Families should rely on official updates and seek guidance from their healthcare providers as the program progresses toward any regulatory submission.
- 1. What is Navax in this context?
The listing describes a combination product named Navax used in a pediatric pneumonia trial, without providing efficacy claims.
- 2. What does Not yet Recruiting mean?
It means enrollment has not started. Updates will appear on ClinicalTrials.gov as the study progresses.
- 3. Why is the term combination product relevant to regulators?
The use of the term signals a potential regulatory pathway that may involve device like elements and therapeutic components under a pediatric framework.
- 4. Where can I find official information?
The official record is on ClinicalTrials.gov with the study identifier NCT07399717 and the term medical device.
Conclusion and implications for practice
This listing signals a regulatory avenue for pediatric pneumonia solutions that blend device and therapeutic components. Until formal filings are available there is no basis for changes in clinical practice. Stakeholders should maintain oversight of the ClinicalTrials.gov entry for status updates and prepare for the regulatory steps that typically follow if the program advances.
Disclaimer: This article is for professionals. It is not legal advice. It is not a substitute for regulatory guidance or clinical decision making. Consult official authorities for instructions relevant to your jurisdiction.
https://clinicaltrials.gov/study/NCT07399717?term=medical+device